Quantitative MRI of uterine leiomyomas during triptorelin treatment: Reproducibility of volume assessment and predictability of treatment response
- 31 December 1996
- journal article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 14 (10) , 1127-1135
- https://doi.org/10.1016/s0730-725x(96)00231-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- MR Detection of Degenerating Uterine LeiomyomasJournal of Computer Assisted Tomography, 1993
- The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one monthEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
- Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.Radiology, 1990
- The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate.American Journal of Roentgenology, 1990
- Uterine leiomyomas in the infertile patient: preoperative localization with MR imaging versus US and hysterosalpingography.Radiology, 1988
- Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imagingAmerican Journal of Obstetrics and Gynecology, 1988
- Toward Removing Uterine Fibroids without Surgery: Subcutaneous Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Commencing in the Luteal PhaseJournal of Clinical Endocrinology & Metabolism, 1986
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms.Radiology, 1986
- MR Imaging of Uterine Leiomyomas and Their ComplicationsJournal of Computer Assisted Tomography, 1985